SSTI Stock Cash Flow Statements

ShotSpotter Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

ShotSpotter Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30

cash flows from operating activities:
net income	-2,909,000	3,643,000	-1,874,000	-2,697,000	-1,790,000	-1,045,000	4,033,000	3,010,000	387,000	-3,311,000	-949,000	-250,000	79,000	-220,000	566,000	866,000	13,000	1,327,000	446,000	387,000	-362,000	302,000	-1,441,000	-369,000	-1,217,000	-2,503,000	-1,610,000
adjustments to reconcile net income to net cash from (used in ) operating activities:
depreciation of property and equipment	1,573,000	1,617,000	1,682,000	1,648,000	1,771,000	1,657,000	1,594,000	1,662,000	1,487,000	1,497,000	1,488,000	1,417,000	1,393,000	1,424,000	1,311,000	1,321,000	1,343,000
amortization of intangible assets	965,000	967,000	793,000	1,499,000	661,000	718,000	692,000	694,000	695,000	258,000	256,000	259,000	259,000	116,000	23,000	24,000	24,000
impairment of property and equipment	252,000	42,000	0	0	72,000					0	0	0	25,000	73,000								54,000	271,000			127,000
stock-based compensation	2,927,000	2,710,000	2,573,000	2,479,000	2,220,000	2,137,000	2,159,000	2,131,000	1,855,000	1,550,000	1,453,000	1,494,000	1,375,000	1,216,000	1,196,000	1,163,000	887,000	682,000	716,000	905,000	754,000	645,000	748,000	648,000	427,000	322,000	231,000
change in fair value of contingent consideration		-4,763,000	82,000	-999,000	-6,000	-312,000	-5,405,000
deferred taxes	41,000	289,000	84,000
allowance for credit losses	126,000	-177,000
changes in operating assets and liabilities:
accounts receivable and contract assets	-4,627,000	-6,503,000
prepaid expenses and other assets	278,000	-950,000	154,000	-75,000	-486,000	655,000	-1,517,000	133,000	-439,000	404,000	164,000	-1,375,000	134,000	-48,000	375,000	-958,000	310,000	111,000	318,000	-816,000	195,000	125,000	-323,000	-579,000	11,000	16,000	-62,000
accounts payable	-886,000	-595,000	2,121,000	-651,000	219,000	687,000	-545,000			-63,000	370,000	-98,000	145,000	-5,000	220,000	157,000	-562,000	374,000	-103,000	-168,000	-346,000	-1,061,000	-390,000	800,000	305,000	-138,000	736,000
accrued expenses and other liabilities	-1,438,000	330,000	880,000
deferred revenue	8,675,000	3,706,000	-1,207,000	1,536,000	-6,261,000	6,751,000	1,217,000	245,000	3,417,000	4,885,000	2,046,000	-5,218,000	430,000	3,923,000	-1,665,000	-2,280,000	-2,370,000	5,624,000	-1,776,000	-1,393,000	344,000	3,737,000	2,975,000	-572,000	706,000	30,000	1,349,000
net cash from operating activities	4,977,000	316,000	9,330,000	2,503,000	-1,198,000	2,115,000	10,289,000			4,447,000	239,000	6,632,000	-1,496,000	2,400,000	3,596,000	-513,000	5,726,000	2,541,000	3,460,000	-1,214,000	8,905,000	-3,901,000	3,351,000	1,388,000	-2,224,000	1,827,000	476,000
capex	-2,134,000	-703,000	-1,134,000	-1,679,000	-1,537,000	-1,889,000	-4,273,000			-2,208,000	-2,059,000	-2,340,000	-1,233,000	-927,000	-1,104,000	-1,391,000	-494,000	-1,151,000	-1,309,000	-1,467,000	-896,000	-1,018,000	-1,783,000	-2,658,000	-2,985,000	-1,883,000	-1,677,000
free cash flows	2,843,000	-387,000	8,196,000	824,000	-2,735,000	226,000	6,016,000			2,239,000	-1,820,000	4,292,000	-2,729,000	1,473,000	2,492,000	-1,904,000	5,232,000	1,390,000	2,151,000	-2,681,000	8,009,000	-4,919,000	1,568,000	-1,270,000	-5,209,000	-56,000	-1,201,000
cash flows from investing activities:
purchase of property and equipment	-2,134,000	-703,000	-1,134,000	-1,679,000	-1,537,000	-1,889,000	-4,273,000	-2,853,000	-1,900,000	-2,208,000	-2,059,000	-2,340,000	-1,233,000	-927,000	-832,000	-1,183,000	-1,117,000	-1,151,000	-1,309,000	-1,467,000	-896,000	-1,018,000	-1,783,000	-2,658,000	-2,985,000	-1,883,000	-1,677,000
investment in intangible and other assets	-6,000	3,000	-390,000	-27,000	-23,000	18,000	-7,000	-9,000	-8,000	-14,000	-13,000	-19,000	-13,000	-26,000	-12,000	-10,000	-24,000	-27,000	-20,000	-5,000	-34,000	-12,000	-10,000	-16,000	-10,000	-21,000	-31,000
net cash from investing activities	-2,140,000	-700,000	-12,519,000	-1,706,000	-1,560,000	-1,871,000	-4,280,000	-2,862,000	-6,526,000	-2,222,000	-2,072,000	-2,359,000	-1,231,000	-15,580,000	-844,000	-1,193,000	-1,141,000	-1,178,000	-1,329,000	-1,472,000	-930,000	-2,741,000	-1,793,000	-2,674,000	-2,995,000	-1,904,000	-1,708,000
cash flows from financing activities:
payment of contingent consideration liability		0	0	0	-1,500,000					0	0	0	-403,000	0	0	0	-347,000
proceeds from line of credit	3,000,000	0
proceeds from exercise of stock options		3,000	3,000	17,000	127,000	274,000	249,000	2,000	13,000	5,000	316,000	364,000	213,000	147,000	69,000	40,000	58,000	11,000	95,000	129,000	219,000	27,000	73,000	108,000	342,000	14,000	31,000
repurchases of common stock		0	-1,947,000	-2,392,000	-1,256,000	0	0	-1,450,000	-1,634,000	0	-918,000	-491,000	-2,192,000	0	0			-3,252,000
payment of line of credit	-3,000,000
net cash from financing activities				-1,892,000	-2,629,000	582,000	249,000	-959,000	-1,621,000	375,000	-602,000	335,000	-2,374,000	435,000	65,000	-1,167,000	-289,000	-3,010,000	-3,351,000	504,000	11,339,000	515,000	62,000	1,518,000	342,000	321,000	-14,630,000
change in cash, cash equivalents and restricted cash	2,837,000	-124,000	1,867,000	-1,095,000	-5,387,000
effect of exchange rate on cash and cash equivalents	-16,000	27,000	8,000	-55,000	-17,000	49,000	-80,000	-102,000	80,000	-78,000	-18,000	19,000	-2,000	122,000	25,000	20,000	-169,000	59,000	-74,000	30,000	-8,000	-3,000	-83,000	-123,000	42,000	68,000	-3,000
cash, cash equivalents and restricted cash at beginning of year	5,703,000		0	0	10,479,000	0	0	0	15,636,000								24,550,000	0	0	0	10,278,000			0	19,597,000
cash, cash equivalents and restricted cash at end of period	8,524,000		1,875,000				6,178,000										28,677,000		-1,294,000	-2,152,000	29,584,000	-6,130,000	1,537,000	109,000	14,762,000
supplemental cash flow disclosures:
property and equipment purchases included in accounts payable	584,000	253,000	-304,000	-546,000	1,074,000	204,000	-903,000	372,000	731,000	109,000	-44,000	-92,000	590,000
adjustments to reconcile net income to net cash from operating activities:
business acquisition, net of cash acquired		0				0	0	0	-4,618,000
proceeds from exercise of warrants										0	0	0	8,000					0	20,000			0	-1,000
proceeds from employee stock purchase plan		257,000	0			308,000	0			370,000	0			296,000	0			231,000	0			488,000	0
cash, cash equivalents at beginning of year
cash, cash equivalents at end of year
estimated fair value of contingent consideration for business combination at closing
fair value of common stock issued as consideration for acquisitions		0
net cash from (used) in financing activities
supplemental disclosure of non-cash financing activities:
fair value of contingent consideration for acquisitions
benefit from accounts receivable				227,000	25,000	0	0	-151,000	77,000		53,000	-84,000	44,000	33,000	-8,000
accounts receivable and contract asset				-1,107,000	4,211,000	-10,759,000	7,754,000	-6,549,000	-4,976,000	-2,748,000	-6,074,000	9,538,000	-3,929,000	-5,023,000	981,000	-575,000	6,570,000
estimated fair value of contingent consideration							0
fair value of common stock issued as consideration for business acquisition						0	0	0	14,266,000
accrued expenses and other current liabilities					-1,834,000	941,000	307,000	919,000	-1,220,000	1,988,000	1,432,000	949,000	-1,451,000	911,000	435,000	-280,000	-491,000	181,000	437,000	300,000	-810,000	-1,106,000	1,561,000	133,000	-834,000	1,049,000	702,000
cash, cash equivalents and restricted cash at end of year					5,075,000				8,852,000
loss on disposal of property and equipment														0	1,000	0	2,000
payment of line of credit costs														-8,000								0
decrease in cash, cash equivalents and restricted cash							6,258,000	-5,324,000	-6,864,000
net cash from (used in ) operating activities									1,283,000
cash paid for income taxes
fair value of contingent consideration									12,400,000
proceeds from issuance of common stock upon secondary offering																		0	0	0	11,247,000
payments of secondary offering costs
increase in cash, cash equivalents and restricted cash																	4,296,000	-1,647,000	-1,220,000	-2,182,000	19,314,000	-6,127,000
business acquisition purchase price adjustment											0
increase in cash and cash equivalents											-2,435,000	4,608,000	-5,101,000		2,817,000											244,000	-15,862,000
cash and cash equivalents at beginning of year											0	0	16,043,000		0											0	0
cash and cash equivalents at end of period											-2,453,000	4,627,000	10,940,000		2,842,000											312,000
proceeds from business acquisition purchase price adjustment													15,000
deferred offering costs included in other assets																						0	183,000
line of credit costs included in other assets																						0
proceeds from issuance of common stock in public offering
payments of offering costs																			0	-318,000	-127,000						-1,012,000
purchases of property and equipment included in accounts payable															-272,000	-208,000	623,000
offering costs included in accounts payable																					317,000
depreciation and amortization																		1,341,000	1,239,000	1,164,000	1,238,000	1,151,000	991,000	958,000	817,000	847,000	866,000
amortization of debt issuance costs																										0	48,000
remeasurement of convertible preferred stock warrant liability																										0	0
loss on early extinguishment of debt																										0
business acquisition
proceeds from initial public offering, net of commissions and discounts																										0	0
proceeds from notes payable																										0	0
repayment of notes payable																										0
payment of debt issuance costs																										0	0
payment on debt extinguishment costs
payments of initial public offering costs
cash paid for interest																										0	514,000
conversion of convertible preferred stock into common stock																										0	0
reclassification of convertible preferred stock warrant liability into additional paid-in capital																										0	0
issuance of warrants in connection with the issuance of notes payable
accounts receivable																			2,183,000	-1,593,000	7,892,000				-2,439,000	2,217,000	-3,069,000
supplemental disclosure of non-cash operating activities:
benefit from doubtful accounts
accounts receivable and unbilled revenue																							-1,041,000
payment of debt extinguishment costs
payment of offering costs
cash, cash equivalents and restricted cash at beginning of period
issuance of warrants in connection with the issuance of notes payable to a financial institution																											0
decrease in cash and cash equivalents																									-4,877,000
debt origination fees included in accrued expenses and other current liabilities
proceeds from issuance of series b-1 convertible preferred stock, net of issuance costs
repayment of line of credit
proceeds from espp
deferred offering costs included in accounts payable and accruals																											-973,000
cash and cash equivalents at end of year

We provide you with 20 years of cash flow statements for ShotSpotter stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ShotSpotter stock. Explore the full financial landscape of ShotSpotter stock with our expertly curated income statements.

The information provided in this report about ShotSpotter stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.